T2 Biosystems (TTOO) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Britain will not join Canada-led defence bank initiative
- Oil inches higher, stays near six-month highs on Saudi attacks
T2 Biosystems Reports 2015 Third Quarter Results
November 2, 2015 4:00 PM ESTLEXINGTON, Mass., Nov. 02, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems (NASDAQ: TTOO) today reported operating highlights and financial results for the third quarter ended September 30, 2015. Recent operational highlights included:
During the third quarter, the Company signed contracts for the adoption of T2Candida® and the T2Dx® with nine new hospitals in the United States. This brought the total number of hospitals to 19 as of September 30,... MoreT2 Biosystems Announces Leading Hospitals Adopting T2Candida for Sepsis Detection
October 29, 2015 6:30 AM EDTLEXINGTON, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a company developing innovative diagnostic products to improve patient health, today announced that Rhode Island Hospital, the principal teaching hospital of The Warren Alpert Medical School of Brown University, the University of Alabama at Birmingham Hospital and The Statens Serum Institut in Denmark are among the first adopters of its... More
T2 Biosystems Announces Leading Hospitals Adopting T2Candida for Sepsis Detection
October 29, 2015 6:30 AM EDTLEXINGTON, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a company developing innovative diagnostic products to improve patient health, today announced that Rhode Island Hospital, the principal teaching hospital of The Warren Alpert Medical School of Brown University, the University of Alabama at Birmingham Hospital and The Statens Serum Institut in Denmark are among the first adopters of its... More



